Genometrics

What Genometrics does

Genometrics is a Chilean genetic testing services platform headquartered in Santiago, founded in 2012 to address limited access and high cost of genetic testing in the country. The company operates as an authorized local intermediary and distributor for a network of international genetic testing laboratories—including Invitae, Natera, Centogene, Veritas, Fulgent, Prevention Genetics, Labcorp, 3Billion, Medgenome, Oneome, and MNG Laboratories—rather than operating its own laboratory infrastructure. Through these partnerships, Genometrics offers a portfolio of next-generation sequencing (NGS)-based genetic tests across six specialties: hereditary cancer, pediatric genetics, cardiology, reproductive genetics (including NIPT), preventive genetics, and pharmacogenetics.

The business operates a hybrid go-to-market model combining direct-to-consumer channels (WhatsApp scheduling, online booking) with B2B institutional partnerships spanning more than 20 hospitals and clinics across Chile, including Hospital Las Condes, Instituto Nacional del Cáncer, FALP, Clínica Dávila, Hospital de Antofagasta, and others. Revenue is generated primarily through one-time test fees, supplemented by sponsored testing programs funded by pharmaceutical companies (PTC Therapeutics) and foundations (Jeffrey Modell Foundation) that provide free genetic testing for specific patient populations. The company bundles genetic counseling services across the testing journey and has maintained ISO 9001:2015 quality certification since 2018. Per the company's own commentary, its entry into the Chilean market with NGS technology reduced genetic test costs to roughly one-tenth of prior levels and expanded the number of genes covered per test.

Name

Genometrics

Legal name

Genometrics

Website

https://genometrics.cl

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

1–10 employees

Short description

Genometrics is a Santiago-based genetic testing intermediary, founded in 2012, that distributes next-generation sequencing tests from 11+ international laboratories to Chilean patients and 20+ healthcare institutions across six specialties, with bundled genetic counseling and ISO 9001:2015-certified processes.

Ownership category

akta.pro rank

Product category

Genetic Testing Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Genetic & Prenatal Testing Laboratories (HLAFAMAH)

akta.pro secondary industries

Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ), Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD), Molecular Diagnostics & Genomics Laboratories (HLAFAMAE)

Keywords

• Genetic testing services
• Hereditary cancer screening
• Prenatal genetic testing
• Pharmacogenetics testing
• Cardiovascular genetic testing

Headquarters

HQ city

Santiago

HQ country

Chile

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Genetic Testing Services: Genometrics serves as an authorized distributor and representative for international genetic testing laboratories in Chile, providing genetic testing services to patients through healthcare providers and directly. Revenue is generated through test fees for various genetic testing services including prenatal, carrier screening, hereditary cancer, pharmacogenetics, pediatric, and cardiovascular genetics.
2. Sponsored Testing Programs: Free genetic testing programs sponsored by pharmaceutical companies (PTC Therapeutics) and foundations (Jeffrey Modell Foundation) for patients meeting specific criteria, covering conditions like familial amyloid polyneuropathy, FCS, DMD, and primary immunodeficiencies.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels6 records

Core offering

Genometrics provides a portfolio of clinical genetic testing services across six specialties (hereditary cancer, pediatric, cardiology, reproductive, preventive, and pharmacogenetics) by acting as an authorized Chilean representative and sample-logistics intermediary for international reference laboratories such as Invitae, Centogene, Natera, Veritas, Fulgent, and Labcorp. It coordinates sample collection, lab submission, result delivery, and pre/post-test genetic counseling for patients and healthcare institutions across Chile, plus sponsored no-cost testing programs funded by pharmaceutical companies and foundations.

Product overview

Genometrics operates as a genetic testing intermediary and advisory service, offering a portfolio of genetic tests across six specialties: hereditary cancer, pediatric genetics, cardiology, reproductive genetics, preventive genetics, and pharmacogenetics. The company does not operate its own laboratory but partners with international reference laboratories (Invitae, Centogene, Natera, Veritas, Fulgent, and others) to provide testing to Chilean patients. Services are complemented by genetic counseling, sponsored testing programs, and sample logistics coordination. The offering functions as an integrated service layer connecting patients, physicians, and international genetic laboratories.

Differentiator

Problem solved

Functional benefit

Products and services

• Hereditary Cancer Genetic Testing Genetic testing for hereditary cancer syndromes, identifying variants in genes related to cancer predisposition to enable proactive risk assessment and preventive measures for patients and families.
• Pediatric Genetic Testing Gene sequencing to determine the existence of diseases resulting from parental gene combinations or unique individual onset in children.
• Cardiology Genetic Testing Genetic testing for hereditary cardiovascular conditions including arrhythmias, cardiomyopathies, sudden death syndromes, and familial hypercholesterolemia.
• Reproductive Genetics (NIPT, Carrier Screening, Pregnancy Loss) Reproductive genetic testing including Non-Invasive Prenatal Testing (NIPT) via Natera Panorama, carrier screening via Natera Horizon (27+ diseases including SMA, CF, Fragile X), Vistara single-gene NIPT (25 diseases), and Anora pregnancy loss testing.
• Preventive Genetic Testing Genetic testing to estimate individual-specific disease risk and guide personalized preventive actions for cancer and cardiovascular conditions.
• Pharmacogenetics Testing Pharmacogenetic testing to identify genetic variants that determine medication metabolism, alert about effectiveness and exposure levels, detail alternative medications, and recommend adjustments to minimize side effects.
• Sponsored Testing Programs Free genetic testing programs sponsored by pharmaceutical companies and foundations for patients meeting specific criteria, covering conditions like familial amyloid polyneuropathy (PTC Therapeutics), FCS, DMD (PTC Therapeutics), and primary immunodeficiencies (Jeffrey Modell Foundation).
• Genetic Counseling Services Pre- and post-test genetic counseling services that collect family history, estimate risk levels, guide patient decision-making, identify appropriate genetic studies, help interpret results and recommendations, and follow up on family-level risk.

Quantifiable outcome

• Reduced genetic testing costs to one-tenth of original prices through partnerships with international laboratories using Next-Generation Sequencing (NGS) technology
• +2 more outcomes

Named customers17 records

Segments7 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature9 records

Partnerships

13 partnerships are on record, tiered core.

• PTC TherapeuticscoreGTM or Marketing Partner · 1 January 2023Pharmaceutical company sponsoring free genetic testing programs for patients with familial amyloid polyneuropathy (hATTR), familial chylomicronemia syndrome (FCS), and Duchenne muscular dystrophy (DMD) who meet specific criteria.
• InvitaecoreTechnology or Integration · 1 January 2012Genometrics became the authorized representative for Invitae (California, USA) in Chile in 2012, introducing Next-Generation Sequencing (NGS) technology to the Chilean market which dramatically reduced genetic testing costs.
• NateracoreTechnology or IntegrationAuthorized distributor of Natera products including Panorama NIPT (world's #1 prenatal test), Horizon carrier screening, Vistara single-gene NIPT, and Anora pregnancy loss testing.
• CentogenecoreTechnology or IntegrationPartnership for exome sequencing and microarray testing services.
• OneomecoreTechnology or IntegrationPartnership for pharmacogenetic testing studies.
• VeritascoreTechnology or IntegrationPartnership for genetic testing services including whole genome sequencing.
• FulgentcoreTechnology or IntegrationPartnership for genetic testing panels and services.
• MNG LaboratoriescoreTechnology or IntegrationPartnership for genetic testing services.
• Prevention GeneticscoreTechnology or IntegrationPartnership for genetic testing services.
• LabcorpcoreTechnology or IntegrationPartnership for genetic testing services.
• 3BillioncoreTechnology or IntegrationPartnership for exome testing services.
• MedgenomecoreTechnology or IntegrationPartnership for genetic testing panels.
• Jeffrey Modell FoundationcoreGTM or Marketing PartnerFoundation sponsoring free genetic testing for patients with primary immunodeficiencies. Testing coordinated through Veritas with JMF logistics approval.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Natera: US-based genetic testing company specializing in reproductive health (Panorama NIPT), hereditary cancer, and oncology. Direct overlap with Genometrics on Panorama NIPT, Horizon carrier screening, Vistara, and Anora products, and is simultaneously a lab partner.
• Color Genomics: US-based population genomics and hereditary cancer testing company offering clinical-grade genetic tests. Comparable offering in hereditary cancer and preventive genetics, with a similar DTC + employer channel model.
• Myriad Genetics: US-based molecular diagnostics company focused on hereditary cancer (BRACAnalysis, myRisk) and other specialty genetic tests. Comparable product portfolio in hereditary cancer testing, though serves markets directly rather than through local intermediaries.
• Veritas Genetics: Whole genome sequencing company offering preventive and clinical genetic tests. Lab partner of Genometrics and a direct competitor in the broader preventive genetics category.
• Centogene: Germany-based rare disease and genetic diagnostics company offering exome sequencing, panels, and biomarker services. Partnered with Genometrics in Chile but operates its own direct commercial channels in other markets.
• Invitae: Genetic testing company offering hereditary cancer, reproductive, and rare disease panels. Genometrics is its authorized representative in Chile, and the two compete indirectly on similar test menus in the broader genetics services space.

Broad incumbents

• Laboratory Corporation of America (Labcorp): Large US clinical laboratory services company offering a wide range of genetic and molecular diagnostics. Lab partner of Genometrics, and its acquisition of Invitae creates potential direct competition in Latin America.
• 23andMe: Consumer genetics company offering DTC ancestry and health predisposition tests. Operates broadly in genetic testing with significant brand recognition but does not focus on clinical-grade specialty testing like Genometrics.

Regional players

• Genera: Brazilian direct-to-consumer genetic testing company offering ancestry, health, and pharmacogenomic tests. Comparable LATAM regional peer operating in a similar niche of consumer and clinical genetics.
• MedGenome: India-based genetic diagnostics and genomics company offering clinical testing, panels, and research services. Partner of Genometrics in Chile and a regional player with a comparable genetic testing intermediary model in its home geography.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/genometrics
• Instagraminstagram.com/genometrics_chile

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Genometrics